Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.
Cancer Sci
; 109(1): 103-111, 2018 Jan.
Article
in En
| MEDLINE
| ID: mdl-29077243
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia-Lymphoma, Adult T-Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Mechanistic Target of Rapamycin Complex 1
/
Mechanistic Target of Rapamycin Complex 2
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Sci
Year:
2018
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom